Related Experiment Video
Updated: May 14, 2026
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIIδ
Juan He1, Shan Jiang, Feng-lan Li
1Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China.
Background:
MicroRNAs (miRNAs) participate in the regulation of cardiac hypertrophy. However, it remains largely unknown as to how miRNAs are integrated into the hypertrophic program. Ca/calmodulin-dependent protein kinase II (CaMKII) is a hypertrophic signaling marker. It is not yet clear which miRNAs can regulate CaMKIIδ.
Purpose:
In this study, we identified which miRNAs could regulate CaMKIIδ and how to regulate CaMKIIδ.
Methods:
Through computational and expression analyses, miR-30b-5p was identified as a candidate regulator of CaMKIIδ. Quantitative expression analysis of hypertrophic models demonstrated significant down-regulation of miR-30b-5p compared with control groups. Luciferase reporter assay showed that miR-30b-5p could significantly inhibit the expression of CaMKIIδ. Moreover, through gain-of-function and loss-of-function approaches, we found miR-30b-5p could negatively regulate the expression of CaMKIIδ and miR-30b-5p was a regulator of cardiac hypertrophy.
Conclusion:
Our study demonstrates that the expression of miR-30b-5p is down-regulated in cardiac hypertrophy, and restoration of its function inhibits the expression of CaMKIIδ, suggesting that miR-30b-5p may act as a hypertrophic suppressor.
Insights
MicroRNAs (miRNAs) regulate cardiac hypertrophy. This study found miR-30b-5p suppresses CaMKIIδ, a key marker, suggesting it acts as a hypertrophic suppressor.
Area of Science:
- Molecular biology
- Cardiovascular research
- Gene regulation
Background:
- MicroRNAs (miRNAs) are implicated in cardiac hypertrophy.
- The precise role of miRNAs in the hypertrophic program and their regulation of Ca/calmodulin-dependent protein kinase II (CaMKII) remain unclear.
Purpose of the Study:
- To identify specific miRNAs that regulate CaMKIIδ.
- To elucidate the mechanism by which miR-30b-5p influences CaMKIIδ expression and cardiac hypertrophy.
Main Methods:
- Computational and expression analyses to identify candidate miRNAs.
- Quantitative expression analysis in hypertrophic models.
- Luciferase reporter assays and gain/loss-of-function studies to validate miRNA-target interaction and functional impact.
Main Results:
- miR-30b-5p was identified as a regulator of CaMKIIδ.
- Expression of miR-30b-5p was significantly down-regulated in cardiac hypertrophy models.
- miR-30b-5p directly inhibits CaMKIIδ expression and negatively regulates cardiac hypertrophy.
Conclusions:
- miR-30b-5p expression is reduced in cardiac hypertrophy.
- Restoring miR-30b-5p function inhibits CaMKIIδ expression.
- miR-30b-5p acts as a suppressor of cardiac hypertrophy, offering a potential therapeutic target.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:16Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:07MAPK Signaling Cascades
01:26Cellular Adaptation II: Hypertrophy